Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A, González Barcia M, Gil-Martínez M, Vieites-Prado A, Lema I, Argibay B, Blanco Méndez J, Lamas MJ, Otero-Espinar FJ. Fernández-Ferreiro A, et al. Eur J Pharm Biopharm. 2015 Aug;94:342-51. doi: 10.1016/j.ejpb.2015.06.003. Epub 2015 Jun 14. Eur J Pharm Biopharm. 2015. PMID: 26079831
Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations.
Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodriguez A, Vieites-Prado A, Sobrino T, Herranz M, García-Varela L, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Medín-Aguerre S, Pardo-Montero J, Aguiar P. Fernández-Ferreiro A, et al. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):772-780. doi: 10.1167/iovs.16-20766. Invest Ophthalmol Vis Sci. 2017. PMID: 28146242
In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodríguez A, Vieites-Prado A, Lema I, Herranz M, Gómez-Lado N, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Cortes J, Sánchez-Martínez M, Pardo-Montero J, Aguiar P. Fernández-Ferreiro A, et al. Eur J Pharm Biopharm. 2017 May;114:317-323. doi: 10.1016/j.ejpb.2017.01.023. Epub 2017 Feb 9. Eur J Pharm Biopharm. 2017. PMID: 28189624
Preclinical PET Study of Intravitreal Injections.
Fernández-Ferreiro A, Luaces-Rodríguez A, Aguiar P, Pardo-Montero J, González-Barcia M, García-Varela L, Herranz M, Silva-Rodríguez J, Gil-Martínez M, Bermúdez MA, Vieites-Prado A, Blanco-Méndez J, Lamas MJ, Gómez-Ulla F, Ruibal Á, Otero-Espinar FJ, González F. Fernández-Ferreiro A, et al. Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2843-2851. doi: 10.1167/iovs.17-21812. Invest Ophthalmol Vis Sci. 2017. PMID: 28570736
Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging.
Luaces-Rodríguez A, Díaz-Tomé V, González-Barcia M, Silva-Rodríguez J, Herranz M, Gil-Martínez M, Rodríguez-Ares MT, García-Mazás C, Blanco-Mendez J, Lamas MJ, Otero-Espinar FJ, Fernández-Ferreiro A. Luaces-Rodríguez A, et al. Int J Pharm. 2017 Aug 7;528(1-2):714-722. doi: 10.1016/j.ijpharm.2017.06.060. Epub 2017 Jun 19. Int J Pharm. 2017. PMID: 28634142
[Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis].
Fernández-Ferreiro A, Luaces-Rodríguez A, Díaz-Tomé V, Gil-Martínez M, Rodríguez Ares MT, Touriño Peralba R, Blanco-Méndez J, González-Barcia M, Otero-Espinar FJ, Lamas MJ. Fernández-Ferreiro A, et al. Farm Hosp. 2017 Nov 1;41(6):678-687. doi: 10.7399/fh.10834. Farm Hosp. 2017. PMID: 29112493 Spanish.
95 results